0%
0%
0%
0%
0%
About Universal Ibogaine Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Nicholas Peter Karos
Website
universalibogaine.com
Headquarters
Vancouver
Founded
2018
ISIN
CA91360F1099
Universal Ibogaine, Inc. develops ibogaine based drug franchise to treat addiction and related mental health issues. This helps in interruption and cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Vancouver, Canada.
Nick Karos jubilant by the listing of UI on Frankfurt stock exch
UI CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedeli
Universal Ibogaine’s stock approved by borse Frankfurt
UI's common shares have been listed for trading on the Frankfurt Stock Exchange, or Bourse Frankfurt, under the ticker symbol "JC4". In Canada, UI will continue to trade on the TSX Venture Exchange under the ticker IBO and on the OTCQB under the ticker symbol IBOGF.
$IBO destined to be on top of the TSX-V index
$IBO is one of the handpicked penny stocks in the market today and is racing ahead with full speed, the stock’s financial figures are pretty neat and is expected achieve great heights in the days to come, shares are trading yesterday at $0.0500 with a distinctive spike
Perks handed to UI upon listing on the Frankfurt stock exchangeThe Frankfurt Stock Exchange (FSE) is Germany's largest stock exchange and the leading European destination for Canadian venture capital firms seeking exposure and liquidity in the European market. The FSE enables advanced electronic trading, settlement, and information technologies, allowing it to
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
